Mauro Bove
Director/Board Member bei REGENERX BIOPHARMACEUTICALS, INC.
Vermögen: - $ am 31.03.2024
Profil
Mauro Bove currently works at RegeneRx Biopharmaceuticals, Inc., as Independent Director from 2004, EyeSense AG, as Director, Kato Pharmaceuticals, Inc., as Director, and Zhaoke Ophthalmology Ltd., as Director-Business Development from 2019.
Mr. Bove also formerly worked at Essetifin SpA, as Director, Head-Corporate & Business Development from 1993 to 2014, Adastra Pharmaceuticals, Inc., as Director, and Lee's Pharmaceutical Holdings Ltd., as Senior VP-Corporate & Business Development from 2014 to 2018.
Mr. Bove received his graduate degree in 1980 from the University of Parma.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Mauro Bove
| Unternehmen | Position | Beginn |
|---|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Director/Board Member | 01.01.2004 |
| ZHAOKE OPHTHALMOLOGY LIMITED | Corporate Officer/Principal | 01.01.2019 |
EyeSense AG
 EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | Director/Board Member | - |
Kato Pharmaceuticals, Inc.
 Kato Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kato Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. The firm engages in the development of therapies for pathologies of the eye. It focuses on disease progression and diabetic retinopathy. The company was founded by Olav B. Bergheim and Terrance S. McGovern and is headquartered in Laguna Hills, CA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Mauro Bove
| Unternehmen | Position | Ende |
|---|---|---|
| LEE'S PHARMACEUTICAL HOLDINGS LIMITED | Director/Board Member | 01.12.2018 |
Essetifin SpA
 Essetifin SpA Pharmaceuticals: MajorHealth Technology Essetifin SpA operates as a holding company. The company was founded in 1957 and is headquartered in Rome, Italy. | Director/Board Member | 31.03.2014 |
Adastra Pharmaceuticals, Inc.
 Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Adastra Pharmaceuticals, Inc. engages in the provision of clinical and commercial development of proprietary drugs for the treatment of various cancers. The company was founded by Tracy L. Parrott in 2005 and is headquartered in Princeton, NJ. | Director/Board Member | - |
Ausbildung von Mauro Bove
| University of Parma | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| LEE'S PHARMACEUTICAL HOLDINGS LIMITED | Health Technology |
| ZHAOKE OPHTHALMOLOGY LIMITED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Essetifin SpA
Essetifin SpA Pharmaceuticals: MajorHealth Technology Essetifin SpA operates as a holding company. The company was founded in 1957 and is headquartered in Rome, Italy. | Health Technology |
Adastra Pharmaceuticals, Inc.
Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Adastra Pharmaceuticals, Inc. engages in the provision of clinical and commercial development of proprietary drugs for the treatment of various cancers. The company was founded by Tracy L. Parrott in 2005 and is headquartered in Princeton, NJ. | Health Technology |
EyeSense AG
EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | Health Technology |
Kato Pharmaceuticals, Inc.
Kato Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kato Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. The firm engages in the development of therapies for pathologies of the eye. It focuses on disease progression and diabetic retinopathy. The company was founded by Olav B. Bergheim and Terrance S. McGovern and is headquartered in Laguna Hills, CA. | Health Technology |
